NewGenIvf Group (NIVF) shares soared more than 71% in Monday's premarket activity after the company said it has signed a binding term sheet with White Lion Capital for a $100 million equity line of credit that is expandable to $500 million.
Under the terms of the agreement, the company said it will have the option to sell to White Lion up to $100 million in shares of common stock over an initial 36-month period.
NewGenIvf said the $100 million limit could rise to $300 million for mergers and acquisitions activity, and further to $500 million after $250 million has been drawn.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。